Skip to main content
SpringerLink
Log in

Complementary Therapies

  • Chapter
  • First Online:
Inflammatory Bowel Disease Nursing Manual

  • 1444 Accesses

Abstract

“Complementary and alternative medicine (CAM) is used to described a wide variety of methods, procedures, substances, and medical systems. Complementary medicine is practiced in addition to conventional medicine, whereas alternative medicine is intended to replace standard methods. For this reason, alternative methods are generally rejected by the scientific community.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Langhorst J (2006) Gastrointestinale Erkrankungen: Chronisch entzündliche Darmerkrankungen. In: Dobos G, Deuse U, Michalsen A (eds) Chronische Erkrankungen integrativ. Elsevier, Urban & Fischer, Amsterdam

    Google Scholar 

  • Langhorst J, Anthonisen IB, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, Dobos GJ (2005) Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in German patients with inflammatory bowel disease: results from a national survey. Inflamm Bowel Dis 11(3):287–295

    Article  Google Scholar 

Suggested Readings

  • Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, Dobos GJ, Korzenik J (2014) Systematic review on complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohn’s Colitis 9(1):86–106

    Article  Google Scholar 

  • Wieland LS, Manheimer E, Berman BM (2011) Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med 17(2):50–59

    PubMed  PubMed Central  Google Scholar 

  • Langhorst J, Anthonisen I, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, Dobos GJ (2007) Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complement Ther Med 15(1):30–37

    Article  Google Scholar 

  • Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL et al (1999) Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol 94:427–433

    Article  CAS  Google Scholar 

  • Gupta I, Parihar A, Malhotra P et al (2001) Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 67:391–395

    Article  CAS  Google Scholar 

  • Gupta I, Parihar A, Malhotra P et al (1997) Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 2:37–43

    CAS  PubMed  Google Scholar 

  • Gerhardt H, Seifert F, Buvari P et al (2001) Therapy of active Crohn disease with Boswellia serrata extract H15. Z Gastroenterol 39:11–17

    Article  CAS  Google Scholar 

  • Holtmeier W, Zeuzem S, Preiss J et al (2011) Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn’s disease: good safety profile but lack of efficacy. Inflamm Bowel Dis 17(2):573–582

    Article  Google Scholar 

  • Langhorst J, Varnhagen I, Schneider SB, Albrecht U, Rueffer A, Stange R, Michalsen A, Dobos GJ (2013a) Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis – a double-blind, double dummy study. Aliment Pharmacol Ther 38(5):490–500

    Article  CAS  Google Scholar 

  • Biedermann L, Mwinyi J, Scharl M et al (2013) Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot study. J Crohns Colitis 7(4):271–279

    Article  Google Scholar 

  • Huber R, Ditfurth AV, Amann F et al (2007) Tormentil for active ulcerative colitis: an open-label, dose-escalating study. J Clin Gastroenterol 41:834–838

    Article  Google Scholar 

  • Hanai H, Iida T, Takeuchi K et al (2006) Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4:1502–1506

    Article  CAS  Google Scholar 

  • Lang A, Salomon N, Wu JCY et al (2015) Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol 13:1444–1449

    Article  CAS  Google Scholar 

  • Omer B, Krebs S, Omer H, Noor TO (2007) Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study. Phytomedicine 14(2–3):87–95

    Article  CAS  Google Scholar 

  • Krebs S, Omer TN, Omer B (2010) Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease - a controlled clinical trial. Phytomedicine 17(5):305–309

    Article  CAS  Google Scholar 

  • Langmead L, Feakins RM, Goldthorpe S et al (2004) Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 19:739–747

    Article  CAS  Google Scholar 

  • Ben-Arye E, Goldin E, Wengrower D et al (2002) Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol 37:444–449

    Article  CAS  Google Scholar 

  • Tang T, Targan SR, Li ZS, Xu C, Byers VS, Sandborn WJ (2011) Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther 33(2):194–202

    Article  CAS  Google Scholar 

  • Sandborn WJ, Targan SR, Byers VS, Rutty DA, Mu H, Zhang X, Tang T (2013) Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol 108:90–98

    Article  Google Scholar 

  • Naftali T, Lev LB, Yablecovitch D, Half E, Konikoff FM (2011) Treatment of Crohn’s disease with cannabis: an observational study. Isr Med Assoc J 13(8):455–458

    PubMed  Google Scholar 

  • Naftali T, Bar-Lev Schleider L, Dotan I et al (2013) Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol 11(10):1276–1280

    Article  CAS  Google Scholar 

  • Joos S, Brinkhaus B, Maluche C et al (2004) Acupuncture and moxibustion in the treatment of active Crohn’s disease: a randomized controlled study. Digestion 69:131–139

    Article  Google Scholar 

  • Joos S, Wildau N, Kohnen R et al (2006) Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study. Scand J Gastroenterol 41:1056–1063

    Article  Google Scholar 

  • Ji J, Lu Y, Liu H et al (2013) Acupuncture and moxibustion for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2013:158352

    Article  Google Scholar 

  • Lee DH, Kim JI, Lee MS et al (2010) Moxibustion for ulcerative colitis: a systematic review and meta-analysis. BMC Gastroenterol 10:36

    Article  Google Scholar 

  • Elsenbruch S, Langhorst J, Popkirowa K et al (2005) Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 74:277–287

    Article  Google Scholar 

  • Jedel S, Hoffman A, Merriman P et al (2014) A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis. Digestion 89:142–155

    Article  CAS  Google Scholar 

  • Berrill JW, Sadlier M, Hood K et al (2014) Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. J Crohns Colitis 8(9):945–955

    Article  Google Scholar 

  • Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Andreoli A, Luzi C (1994) Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 89(8):1219–1225

    CAS  PubMed  Google Scholar 

  • Levenstein S, Prantera C, Varvo V et al (2000) Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 95:1213–1220

    Article  CAS  Google Scholar 

  • Langhorst J, Hofstetter A, Wolfe F et al (2013b) Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study. Inflamm Bowel Dis 19:2380–2386

    Article  Google Scholar 

  • Mizrahi MC, Reicher-Atir R, Levy S, Haramati S, Wengrower D, Israeli E, Goldin E (2012) Effects of guided imagery with relaxation training on anxiety and quality of life among patients with inflammatory bowel disease. Psychol Health 27:1463–1479

    Article  Google Scholar 

  • Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS (2013) Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 38:761–771

    Article  CAS  Google Scholar 

  • Sonnenberg A (1990) Occupational mortality of inflammatory bowel diseases. Digestion 46(1):10–18

    Article  CAS  Google Scholar 

  • Khalili H, Ananthakrishnan AN, Konijeti GG et al (2013) Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts. BMJ 347:f6633. https://doi.org/10.1136/bmj.f6633

    Article  PubMed  PubMed Central  Google Scholar 

  • Nunes T, Etchevers MJ, Domènech E, Tobacco-Eneida Study Group of GETECCU et al (2013) Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther 38(7):752–760

    Article  CAS  Google Scholar 

  • Cramer H, Schafer M, Schols M et al (2017) Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis. Aliment Pharmacol Ther 45(11):1379–1389

    Article  CAS  Google Scholar 

  • Schneider A, Streitberger K, Joos S (2007) Acupuncture treatment in gastrointestinal diseases: a systematic review. World J Gastroenterol 13(25):3417–3424

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal and Integrative Medicine, Klinikum Bamberg, Sozialstiftung Bamberg, Bamberg, Germany

    Jost Langhorst

Authors
  1. Jost Langhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jost Langhorst .

Editor information

Editors and Affiliations

  1. DRK Kliniken Berlin Westend, Department of Gastroenterology, Berlin, Germany

    Andreas Sturm

  2. Gastroenterology Level 5, John Radcliffe Hospital, Oxford, UK

    Lydia White

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Langhorst, J. (2019). Complementary Therapies. In: Sturm, A., White, L. (eds) Inflammatory Bowel Disease Nursing Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-75022-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-75022-4_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-75021-7

  • Online ISBN: 978-3-319-75022-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation